Filing Flows

Filing Flows › Zoetis (ZTS) › Next earnings date

Zoetis (ZTS) earnings: beat the estimate

Zoetis (ZTS) reported on Nov 5, 2026 and beat the EPS estimate: $1.75 against $1.51 (+15.8%). Revenue was $2.4B for Q3 2026, -1% year over year. The stock moved -11.0% on the report. It beat the EPS estimate in 80% of the quarters on record.

Last result+15.8% vs estimate
Beat rate80%

The last report

Zoetis reported revenue of $2.4B for the third quarter 2026 (-1% Y/Y), net earnings $591M: Companion Animal $1.6B, Dermatology $398M, Pain and sedation $200M, Swine $120M. How it makes money → · Every quarter →

Zoetis: EPS against the estimate, last 5 reportsZoetis: EPS against the estimate, last 5 reportsEstimateReported$1.62$1.70Nov 25$1.40$1.48Feb 26$1.62$1.53May 26$1.85$1.87Aug 26$1.51$1.75Nov 26
Latest (Nov 26): Estimate $1.51, Reported $1.75.
ZTS: the stock's move on each reportZTS: the stock's move on each reportNov 5, 2026-11.0%Aug 6, 2026-2.3%May 7, 2026-25.5%Feb 12, 2026-1.6%Nov 4, 2025-16.5%

Zoetis' latest quarter

Zoetis, Q3 2026: revenue $2.4B (-1% year over year), operating margin 30.5%, net earnings $591M, operating cash flow $824M. The chart follows the revenue to costs, profit and cash.

Questions

Did Zoetis beat earnings?

Zoetis (ZTS) reported on Nov 5, 2026 and beat the EPS estimate: $1.75 against $1.51 (+15.8%).

When does ZTS report earnings?

The next date is not set yet.

Does Zoetis usually beat earnings?

It beat the consensus EPS estimate in 80% of the quarters on record.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.